Web18 Jun 2024 · Terry Horgan, 24, is suffering from a rare form of muscular dystrophy. His brother Richard created a nonprofit called Cure Rare Disease through which he is working with a geneticist at Yale who is spearheading research into a cure through a gene editing technique called CRISPR. TODAY senior international correspondent Keir Simmons reports. Web4 Nov 2024 · Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try and save him...
Lauren E. Black on LinkedIn: ‘We’re finally here’: Harvard graduate ...
Web7 Apr 2024 · About Richard Horgan Horgan is the founder and president of Cure Rare Disease, a nonprofit biotech that develops custom-made drugs. The organization is currently working on a Crispr-based... Web4 Nov 2024 · This undated photo shows Terry Horgan with his parents in the family's Montour Falls, N.Y., home. Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, Oct. 2024, according to Cure Rare Disease, a Connecticut-based nonprofit … engineering qualifications needed
Death in CRISPR Gene Therapy Study Sparks Search for Answers
Web7 Nov 2024 · Terry Horgan, the primary patient in an N-of-1 clinical trial evaluating a CRISPR-based gene therapy for the treatment of Duchenne muscular dystrophy (DMD), has died, according to an announcement from Cure Rare Disease, the nonprofit biotech sponsoring … Web7 Nov 2024 · Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try and save him from the fatal condition. ... The hope was to use a gene … Web31 Mar 2024 · Terry Horgan was the sole participant in a Phase I study (NCT05514249) designed to evaluate CRD-TMH-001, which is designed to treat a rare mutation of Duchenne muscular dystrophy (DMD). The goal ... dream home makeover season 2